Health Condition 1: I00-I99- Diseases of the circulatory system
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
None
Eligibility
Inclusion criteria
Inclusion criteria: All patients of Chronic Kidney Disease above the age of 18 years. Patients voluntarily willing to give informed consent will be taken for this study.
Exclusion criteria
Exclusion criteria: Family history of thyroid disorder. Known case of thyroid disorders whether having medication or not. History of any surgery or any radiological intervention to thyroid gland. Patients on drugs altering thyroid profile such as amiodarone, phenytoin, oestrogen pills and iodine containing drugs. Pregnant females.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study could be defined as the prevalence of thyroid function abnormalities (such as subclinical hypothyroidism, overt hypothyroidism, hyperthyroidism, and low T3 syndrome) in patients with chronic kidney disease (CKD), categorized according to different stages.Timepoint: BASELINE AND 12 WEEKS | — |
Secondary
| Measure | Time frame |
|---|---|
| This study aims to examine thyroid function in chronic kidney disease (CKD) patients across different stages and assess the prevalence of thyroid abnormalities. Secondary outcomes include investigating correlations between thyroid function and CKD stages, as well as changes in quality of life, estimated glomerular filtration rate (eGFR), and Body Mass Index (BMI) after 3 months of treatment in non-dialysis CKD patients.Timepoint: 1 Month | — |
Countries
India
Contacts
Public ContactDr Amit Pasari
Datta Meghe Institute of Higher Education and Research
Outcome results
None listed